Cargando…
Posterior Reversible Encephalopathy Occurring During Treatment With Palbociclib
Palbociclib (Ibrance™) has been marketed since 2015 for patients with metastatic hormone-receptor-positive breast cancer. We report here the case of a patient who presented with a posterior reversible encephalopathy syndrome (PRES) during treatment with this new targeted therapy. The 67-year-old wom...
Autores principales: | Belaidi, Lahcene, Baba-Hamed, Nabil, Savinelli, Francesco, Raymond, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382279/ https://www.ncbi.nlm.nih.gov/pubmed/34447643 http://dx.doi.org/10.7759/cureus.16604 |
Ejemplares similares
-
An Unexpected Case of Posterior Reversible Encephalopathy Syndrome
por: Baig, Hassan, et al.
Publicado: (2020) -
Cerebrovascular Disease in the Setting of Posterior Reversible Encephalopathy Syndrome
por: Cheng, XiaoQing, et al.
Publicado: (2021) -
Posterior Reversible Encephalopathy Syndrome Secondary to Varicella Encephalitis
por: Dawood, Huzaifa, et al.
Publicado: (2021) -
Editorial: Posterior Reversible Encephalopathy Syndrome and Associated Diseases
por: Legriel, Stephane, et al.
Publicado: (2020) -
Cerebrospinal Fluid Hypovolemia and Posterior Reversible Encephalopathy Syndrome
por: Zheng, Yuan-yuan, et al.
Publicado: (2020)